Gritstone Bio Stock Price, News & Analysis
Company Description
Gritstone Bio (OTC: GRTSQ) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $1.5K.
GRTSQ stock has declined 100.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of GRTSQ stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Gritstone Bio (GRTSQ) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $1.5K, GRTSQ is classified as a micro-cap stock with approximately 118.1M shares outstanding.
Latest News
Gritstone Bio has 1 recent news article. Key topics include clinical trial. View all GRTSQ news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GRTSQ Company Profile & Sector Positioning
Gritstone Bio (GRTSQ) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing GRTSQ often look at related companies in the same sector, including Effector Therapeutics Inc (EFTR), Innoveren Scientific Inc (IVRN), Ampio Pharma (AMPE), Novaccess Global Inc (XSNX), and Statera Biopharma Inc (STAB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GRTSQ's relative position within its industry.